Clinical Trial Update: TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for T-Cell Vaccination (TCV-01-002) in probable multiple sclerosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• T Cell Vaccination

Snippet

Sponsor: Sheba Medical Center | Conditions: Multiple Sclerosis | Phase 3 | Status: UNKNOWN